Molecular PD-L1 PET/CT Imaging With 89Zr-atezolizumab in Metastatic Triple Negative Breast Cancer
Clinical trial NCT05742269 · TERMINATED
Trial details
- NCT number
- NCT05742269
- Sponsor
- Karolinska University Hospital
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2023-07-01
- Primary completion
- 2024-12-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.